CTOR Competitors & Alternatives

Compare Citius Oncology, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

CTOR

Main Stock
$0.92
Tradestie Score
27
Market Cap
$164.52M
Analyst Upside
+336.0%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.78
$711.32M - 40 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$57.08
$543.32M 152.3 43 Compare
EOLS Evolus, Inc. Common Stock
$7.84
$397.82M - 35 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.08
$237.15M 5.2 53 Compare
SLXN Silexion Therapeutics Corp Ordinary Shares
$0.36
$11.85M - 43 Compare
VSEE VSee Health, Inc. Common Stock
$0.05
$10.25M - 42 Compare
IBO Impact BioMedical, Inc.
$0.46
$7.84M 0.6 52 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$11.03
$6.53M - 42 Compare
NIVF NewGenIvf Group Limited Class A ordinary shares
$1.06
$4.04M 0.0 29 Compare

Data updated: Sep 13, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry